Vericiguat Therapy Is Associated with Reverse Myocardial Remodeling in Chronic Heart Failure with Reduced Ejection Fraction
In patients with HFrEF and recent worsening, the addition of vericiguat to GDMT may be associated with reverse myocardial remodeling.
Authors
- Tine Bajec
- Sabina Frljak (ORCID: https://orcid.org/0000-0003-3691-4982)
- Gregor Zemljič (ORCID: https://orcid.org/0000-0001-6082-5176)
- Sabina Ugovšek (ORCID: https://orcid.org/0000-0002-2056-4781)
- R. Okrajšek (ORCID: https://orcid.org/0009-0006-3095-0041)
- A. Cerar (ORCID: https://orcid.org/0000-0002-8881-2251)
- Neža Žorž
- Gregor Poglajen (ORCID: https://orcid.org/0000-0003-1777-8807)
- Petra Girandon Sušanj
- Miran Šebeštjen (ORCID: https://orcid.org/0000-0001-9907-3522)
- Bojan Vrtovec
Institutions
- University of Ljubljana (SI)
- Ljubljana University Medical Centre (SI)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2025-12-29
- DOI
- https://doi.org/10.3390/jcdd13010017
- Primary Topic
- Cardiovascular Function and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00